Uptake of radioactive octanoate in astrocytoma cells: Basic studies for application of [11C]octanoate as a PET tracer

Annals of Nuclear Medicine

Volumn 10, Issue 4, 1996, Pages 395-399

  Yamazaki, Shunji ^a   Fukui, Kiyoshi ^a,b   Kawashima, Hidefumi ^a   Kuge, Yuji ^a   Miyake, Yoshihiro ^a   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

astrocytoma cell culture; pathological conditions

Indexed keywords

CARBON 11; CARBON 14; GLUCOSE; GLUTAMIC ACID; OCTANOIC ACID;

ARTICLE; ASTROCYTOMA; BRAIN HYPOXIA; CONTROLLED STUDY; DRUG UPTAKE; HUMAN; HUMAN CELL; HYPOGLYCEMIA; PH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030456008     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164800     Document Type: Article

References (18)

1. 18F]Fluorooclanoic acid and its β-substituted derivatives as potential agents for cerebral fatty acid studies: synthesis and biodistribution. Nucl Med Biol 11: 809-817, 1994.
2. 11C]hexanoate as a PET tracer of fatty acid metabolism. Ann Nucl Med 9: 51-57, 1995.
3. 11C]octanoate in rats: Pharmacokinetic basis for its application as a radiopharmaceutical for studying brain fatty acid metabolism. Ann Nucl Med 9: 137-142, 1995.
4. 14C]palmitic acid into the adult rat brain. Biochim Biophys Acta 187: 461-467, 1969.
5. Cremer JE, Teal HM, Heath DF, Cavanagh JB. The influence of portocaval anastomosis on the metabolism of labelled octanoate, butyrate and leucine in rat brain. J Neurochem 28: 215-222, 1977.
6. Oldendorf WH. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol 224: 1450-1453, 1973.
7. Edmond J, Robbins RA, Bergstrom JD, Cole RA, de Vellis J. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res 18: 551-561, 1987.
8. Edmond J. Energy metabolism in developing brain cells. Can J Physiol Pharmacol 70: S118-S129, 1992.
9. Petio CK, Morgello S, Felix JC, Lesser ML. The two patterns of reactive astrocytosis in postischemic rat brain. J Cereb Blood Flow Metab 10: 850-859, 1990.
10. Petio CK, Chung MC, Verkhovsky LM, Cooper AJL. Brain glutamine synthetase increases following cerebral ischemia in the rat. Brain Res 569: 275-280, 1992.
11. Fowler JS, Gallagher BM, MacGregor RR, Wolf AP. Carbon-11 labelled aliphatic amines in lung uptake and metabolism studies: Potential for dynamic measurements in vivo. J Pharmacol Exp Ther 198: 133-145, 1976.
12. Reeves SA, Helman LJ, Allison A, Israel MA. Molecular cloning and primary structure of human glial fibrillary acidic protein. Proc Natl Acad Sci USA 86: 5178-5182, 1989.
13. Gibbs CS, Cambell KE, Wilson RH. Sequence of a human glutamine synthetase cDNA. Nucleic Acids Res 15: 6293, 1987.
14. Goldberg MP, Weiss JH, Pham P, Choi DW. N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. J Pharmacol Exp Ther 243: 784-791, 1987.
15. Yu ACH, Gregory GA, Chan PH. Hypoxia-induced dysfunctions and injury of astrocytes in primary cell cultures. J Cereb Blood Flow Metab 9: 20-28, 1989.
16. Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes in rat brain. Brain Res 161: 303-310, 1979.
17. Spector R. Fatty acid transport through the blood-brain barrier. J Neurochem 50: 639-643, 1988.
18. Müller U, Krieglstein J. Prolonged pretreatment with α-lipoic acid protects cultured neurons against hypoxic, glutamate-, or iron-induced injury. J Cereb Blood Flow Metab 15: 624-630, 1995.